PharmiNews

Directory of Pharma Companies and News

Home

Latest News

E_DEPRECATED Error in file »index-code.php« at line 146: Function utf8_encode() is deprecated E_DEPRECATED Error in file »functions_general.php« at line 301: Function utf8_encode() is deprecated E_DEPRECATED Error in file »functions_general.php« at line 301: Function utf8_encode() is deprecated E_DEPRECATED Error in file »functions_general.php« at line 301: Function utf8_encode() is deprecated E_DEPRECATED Error in file »functions_general.php« at line 301: Function utf8_encode() is deprecated E_DEPRECATED Error in file »functions_general.php« at line 301: Function utf8_encode() is deprecated E_DEPRECATED Error in file »functions_general.php« at line 301: Function utf8_encode() is deprecated E_DEPRECATED Error in file »functions_general.php« at line 301: Function utf8_encode() is deprecated E_DEPRECATED Error in file »functions_general.php« at line 301: Function utf8_encode() is deprecated E_DEPRECATED Error in file »functions_general.php« at line 301: Function utf8_encode() is deprecated E_DEPRECATED Error in file »functions_general.php« at line 301: Function utf8_encode() is deprecated
BioMarin Resubmits Biologics License Application (BLA) for Valoctocogene Roxaparvovec AAV Gene Therapy for Severe Hemoph...
2022-09-29
LECANEMAB CONFIRMATORY PHASE 3 CLARITY AD STUDY MET PRIMARY ENDPOINT, SHOWING HIGHLY STATISTICALLY SIGNIFICANT REDUCTION...
2022-09-28
METOJECT® SUBCUTANEOUS INJECTION SYRINGE (METHOTREXATE) APPROVED IN JAPAN FOR RHEUMATOID ARTHRITIS
2022-09-26
Change in the Roche Board of Directors
2022-09-26
Notice of Purchase of Treasury Shares as a Result of the Processing of Fractional Shares Through Share Exchange (Purchas...
2022-09-26
RELEASE OF DEMENTIA DISEASE AWARENESS VIDEOS FOR WORLD ALZHEIMER’S DAY, SEPTEMBER 21
2022-09-21
European Commission approves Roche’s Vabysmo, the first bispecific antibody for the eye, for two leading causes of visio...
2022-09-19
BioMarin's Gene Therapy for Adults with Severe Hemophilia A, ROCTAVIAN™ (valoctocogene roxaparvovec), Assessed to Provid...
2022-09-15
Eisai Presents Results of Post Hoc Analysis of Eribulin Mesylate (HALAVEN®) at the European Society for Medical Oncology...
2022-09-12
Eisai and Merck & Co., Inc., Rahway, NJ, USA Present Results From Phase 3 LEAP-002 Trial Evaluating LENVIMA® (lenvatinib...
2022-09-12

(updated)

Brought to you by PharmiWeb.com - Latest Jobs in Pharma
Page generated in 0.0567 seconds.